Skip to Main Content

Author Details

Leszek Miszczyk
MSC National Research Institute of Oncology Gliwice Branch
1996
123
17
PMIDPaper TitleJournal TitlePublished Year
36830825The Effectiveness and Toxicity of Frameless CyberKnife Based Radiosurgery for Parkinson's Disease-Phase II Study.Biomedicines2023
36831523Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity.Cancers (Basel)2023
33942509Microbiological effects in patients with leg ulcers and diabetic foot treated with Lucilia sericata larvae.Int Wound J2022
36275129Overview of the current role of stereotactic body radiotherapy in the treatment of unfavorable intermediate- and high-risk prostate cancer.J Radiosurg SBRT2022
35949621Role of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio and platelets in prognosis of patients with prostate cancer.Oncol Lett2022
36184997Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas - A randomized clinical trial.Radiother Oncol2022
35311130Do We Need Radiotherapy in Grade II Ependymoma?Front Oncol2022
34774650Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.Radiother Oncol2022
33035622Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.Radiother Oncol2021
33768769Prognostic factors in postoperative radiotherapy for prostate cancer - tertiary center experience.Radiol Oncol2021
35076586Thymic Tumours in Children.Pediatr Rep2021
34667441Noninvasive celiac plexus radiosurgery in palliative treatment for patients with symptomatic pancreatic cancer.Contemp Oncol (Pozn)2021
33339899Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma.Bone Marrow Transplant2021
33293501Radiation therapy in patients with cardiac implantable electronic devices.Kardiol Pol2021
32988916Bladder-conserving Approach in Radical Treatment of Patients With Bladder Cancer - A Single-institution Experience.Anticancer Res2020
31721044The results of 394 consecutive cases of knee joint radiation synovectomy (radiosynoviorthesis) using <sup>90</sup>Y.Ann Nucl Med2020
32663537Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.Radiother Oncol2020
32960662Randomised clinical trial on 7-days-a-week postoperative radiotherapy vs. concurrent postoperative radio-chemotherapy in locally advanced cancer of the oral cavity/oropharynx.Br J Radiol2020
31276777Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.Int J Radiat Oncol Biol Phys2019
31741466Patients with cardiac implantable electronic devices undergoing radiotherapy in Poland. Expert opinion of the Heart Rhythm Section of the Polish Cardiac Society and the Polish Society of Radiation Oncology.Kardiol Pol2019
31462169Stereotactic Ablative Radiotherapy for Prostate Cancer-The Treatment Results of 500 Patients and Analysis of Failures.Technol Cancer Res Treat2019
29330481FDXR is a biomarker of radiation exposure in vivo.Sci Rep2018
30174881Primary mediastinal seminoma.J Thorac Dis2018
29983098Salvage CyberKnife-Based Reirradiation of Patients With Recurrent Prostate Cancer: The Single-Center Experience.Technol Cancer Res Treat2018
29928948Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study.Int J Radiat Oncol Biol Phys2018
30482212A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.Radiat Oncol2018
29787434Influence of Confounding Factors on Radiation Dose Estimation Using In Vivo Validated Transcriptional Biomarkers.Health Phys2018
28545199Cyberknife Radioablation of Prostate Cancer â¿¿ Preliminary Results for 400 PatientsAsian Pac J Cancer Prev2017
29696952[CyberKnife for prostate cancer patients. Update of 200 patients treatment results].Przegl Lek2017
28699351Ultrahypofractionated CyberKnifeTM based stereotactic radiotherapy versus conventional radiotherapy in patients with prostate cancer - acute toxicity evaluation in two phase II prospective studies.Neoplasma2017
26208835CyberKnife Stereotactic Ablative Radiotherapy as an Option of Treatment for Patients With Prostate Cancer Having Oligometastatic Lymph Nodes: Single-Center Study Outcome Evaluation.Technol Cancer Res Treat2016
26541822Impact of intrafractional respiratory-induced prostate mobility on PTV size.Tumori2016
27904449Tracheal cancer - treatment results, prognostic factors and incidence of other neoplasms.Radiol Oncol2016
26774153CyberKnife stereotactic radiosurgery and stereotactic ablative radiation therapy of patients with prostate cancer bone metastases.Neoplasma2016
26934504Randomized clinical trial on 7-days-a-week post-operative radiotherapy vs concurrent post-operative radiochemotherapy in locally advanced cancer of the oral cavity/oropharynx: a report on acute normal tissue reactions.Br J Radiol2016
25591599Daily image-guidance in prostate cancer radiotherapy - implications for treatment margins.Neoplasma2015
28248265Partial-Body Irradiation in Patients with Prostate Cancer Treated with IMRT Has Little Effect on the Composition of Serum Proteome.Proteomes2015
26568868CyberKnife-based prostate cancer patient radioablation - early results of irradiation in 200 patients.Cent European J Urol2015
26557782Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases.Contemp Oncol (Pozn)2015
26452009Lower Risk of Cancer in the Areas Inhabited by the German Minority in the Region of Opole, Poland.Oncol Res Treat2015
26751747An Evaluation of Radiotherapy Effectiveness for Epicondylitis Humeri (EPH).Ortop Traumatol Rehabil2015
26144843Acute toxicity of robotic ultrahypofractionated radiotherapy CyberKnifeTM in prostate cancer patients.Neoplasma2015
25884489The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.Radiat Oncol2015
26031365Serum Proteome Signature of Radiation Response: Upregulation of Inflammation-Related Factors and Downregulation of Apolipoproteins and Coagulation Factors in Cancer Patients Treated With Radiation Therapy--A Pilot Study.Int J Radiat Oncol Biol Phys2015
24712261[CyberKnife based radiosurgery in gynecological oncology--application and preliminary results].Przegl Lek2014
25951698[The influence of radiotherapy of head and neck cancers on carotid arteries].Przegl Lek2014
25477762Interrelation between population density and cancer incidence in the province of Opole, Poland.Contemp Oncol (Pozn)2014
25298327Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients.J Ovarian Res2014
25058109The results of treatment of prostate cancer bone metastases after CyberKnife radiosurgery.Ortop Traumatol Rehabil2014
25027170Split-course accelerated hyperfractionated irradiation (CHA-CHA) as a sole treatment for advanced head and neck cancer patients-final results of a randomized clinical trial.Br J Radiol2014
  • 1 - 50 of 123

Recommended Authors

Arne Gruen
Charite-University Hospital Berlin
Career Start Year 2010
Number of shared co-authors 0
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 3
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 2
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 21
Coen R N Rasch
Leiden University Medical Center
Career Start Year 1997
Number of shared co-authors 1
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 7
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Career Start Year 1996
Number of shared co-authors 2
Jong Hoon Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Career Start Year 1994
Number of shared co-authors 16
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 2
Rafael Mart??nez-Monge
Clinica Universitaria de Navarra
Career Start Year 1993
Number of shared co-authors 16
Philippe Lambin
Maastricht University
Career Start Year 1992
Number of shared co-authors 1
William L Barrett
Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA.
Career Start Year 1992
Number of shared co-authors 0
Karin Dieckmann
Medical University of Vienna
Career Start Year 1991
Number of shared co-authors 0
Stefan K??nemann
Switzerland Ecole Polytechnique Federal de Lausanne, EPFL
Career Start Year 1991
Number of shared co-authors 1
Ivy A Petersen
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 0
William F Hartsell
Proton Therapy Center- Northwestern University
Career Start Year 1989
Number of shared co-authors 1
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Career Start Year 1988
Number of shared co-authors 14
Robert L Foote
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 1
Tsutomu Saito
Nihon University School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Danielle Van den Weyngaert
University of Antwerp
Career Start Year 1987
Number of shared co-authors 0
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Career Start Year 1987
Number of shared co-authors 15
Peter Hoskin
Mount Vernon Cancer Centre
Career Start Year 1985
Number of shared co-authors 11
Vincenzo Valentini
Universita Cattolica del Sacro Cuore
Career Start Year 1983
Number of shared co-authors 1
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 1
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 2
Andre Konski
Chester County Hospital
Career Start Year 1982
Number of shared co-authors 3
James W Denham
University of Newcastle
Career Start Year 1980
Number of shared co-authors 17
Michel Bolla
universite Grenoble-Alpes (UGA)
Career Start Year 1971
Number of shared co-authors 14

Collaborators

Aleksandra Napieralska
MSC National Research Institute of Oncology Gliwice Branch
Co-authored papers 17
Agnieszka Namys??-Kaletka
Maria Sklodowska-Curie National Research and Institute of Oncology
Co-authored papers 8
Mark K Buyyounouski
Stanford University
Co-authored papers 4
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 4
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 4
Hilary P Bagshaw
Stanford University
Co-authored papers 4
Simeng Suy
MedStar Georgetown University Hospital
Co-authored papers 4
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 4
Amar U Kishan
University of California los angeles
Co-authored papers 4
Michael L Steinberg
University of California los angeles
Co-authored papers 4
Constantine A Mantz
University of Chicago
Co-authored papers 4
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 3
Naomi Y Jiang
University of California los angeles
Co-authored papers 3
Alan W Katz
University of Rochester
Co-authored papers 3
Audrey Dang
Tulane University School of Medicine
Co-authored papers 3
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 3
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 3
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 3
Ye Yuan
Southwest Hospital, Army Medical University
Co-authored papers 3
Shrinivasa K Upadhyaya
University of California davis
Co-authored papers 2
Minsong Cao
University of California Los Angeles
Co-authored papers 2
Rebecca Levin-Epstein
University of California los angeles
Co-authored papers 2
Donald B Fuller
Division of Genesis Healthcare Partners Inc., CyberKnife Centers of San Diego Inc.
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
William C Jackson
University of Michigan ann arbor
Co-authored papers 2
Brandon A Mahal
Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine
Co-authored papers 2
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
Agnieska Namys??-Kaletka
Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Co-authored papers 1
Sartajdeep Kahlon
University of California los angeles
Co-authored papers 1
Rebecca Philipson
Torrance Memorial Hospital
Co-authored papers 1
Release 1.2